BNPとNTproBNPの世界市場レポート 2024年

BNPとNTproBNPの市場規模は近年急速に拡大しています。2023年の17億7,000万米ドルから2024年には20億米ドルへと、CAGR13.2％で拡大します。過去に見られた拡大は、人口の高齢化、心不全の診断におけるこれらの検査の臨床的意義、心血管医学分野における顕著な進歩、予防医療対策の重視の高まりなど、いくつかの要因に起因しています。

心血管疾患の有病率の増加は、BNPとNTproBNP市場の今後の成長を促進します。これらの疾患は心臓や血管に影響を及ぼし、末梢動脈疾患、脳血管疾患、冠状動脈性心疾患などの疾患を含みます。BNPとNTproBNP検査は心臓の健康モニタリングにおいて重要な役割を果たし、心血管疾患の要因を特定することで先手を打ち、死亡リスクを低減します。例えば、英国国家統計局によると、心臓発作に起因する死亡者数は2020年の1万9,440人から2021年には2万61人に増加します。このような心血管疾患の急増は、BNPとNTproBNP市場の成長の起爆剤となります。

高齢者人口層の拡大はBNPとNTproBNP市場拡大の原動力になると予測されます。このセグメントは65歳以上の高齢者で構成され、心不全の診断と管理においてBNPとNTproBNP検査が重要な助けとなります。これらのバイオマーカーは心機能に関する貴重な洞察を提供し、高齢者に合わせた治療戦略の一助となります。世界保健機関（WHO）の報告によると、2030年までに世界の6人に1人が60歳以上になり、2050年には21億人の高齢者に達すると予測されています。したがって、急増する高齢者人口がBNPとNTproBNP市場の成長を後押ししています。

アジア太平洋は、2023年のBNPとNTproBNP市場において最大の地域です。北米は予測期間中、BNPとNTproBNP世界市場レポートにおいて最も急成長している地域になると予測されています。BNPとNTproBNP市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のBNPとNTproBNP市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のBNPとNTproBNPの市場規模実績と成長、2018～2023年
• 世界のBNPとNTproBNP市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のBNPとNTproBNP市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• BNP（脳性ナトリウム利尿ペプチド）
• NTproBNP（N末端Pro-B型ナトリウム利尿ペプチド）
• 世界のBNPとNTproBNP市場、試験場所別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• ポイントオブケア検査
• 臨床検査
• 世界のBNPとNTproBNP市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 心筋梗塞
• うっ血性心不全
• 急性冠症候群（ACS）
• その他の用途

第7章 地域と国の分析

• 世界のBNPとNTproBNP市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のBNPとNTproBNP市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• BNPとNTproBNP市場の競合情勢
• BNPとNTproBNP市場の企業プロファイル
  • Abbott Laboratories
  • Gentian Diagnostics ASA
  • Siemens AG
  • PerkinElmer Inc.
  • Biomerieux SA

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

“BNP And NTproBNP Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bnp and ntprobnp market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bnp and ntprobnp? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The bnp and ntprobnp market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: BNP (Brain Natriuretic Peptide); NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide)
• 2) By Location Of Testing: Point Of Care Testing; Laboratory Testing
• 3) By Application: Myocardial Infarction; Congestive Heart Failure; Acute Coronary Syndrome (ACS); Other Applications
• Companies Mentioned: Abbott Laboratories; Gentian Diagnostics ASA; Siemens AG; PerkinElmer Inc.; Biomerieux SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) tests are diagnostic assessments gauging the levels of either BNP or its precursor hormone NT-proBNP in the blood. These tests serve as indicators for heart failure and various cardiac conditions. BNP and NT-proBNP, categorized as natriuretic peptides, hold pivotal roles in regulating circulation. Elevated levels of BNP or NT-proBNP typically signify underlying heart disease, specifically abnormalities in blood pumping.

These tests primarily involve measuring the quantities of BNP (brain natriuretic peptide) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) in the bloodstream. The BNP test specifically targets BNP levels, aiding in the detection of heart failure and other cardiac conditions. Testing locations encompass both point-of-care and laboratory settings, facilitating diagnostics for myocardial infarction, congestive heart failure, acute coronary syndrome (ACS), and other related ailments.

The BNP and NTproBNP market research report is one of a series of new reports from The Business Research Company that provides BNP and NTproBNP market statistics, including the BNP and NTproBNP industry global market size, regional shares, competitors with a BNP and NTproBNP market share, detailed BNP and NTproBNP market segments, market trends, and opportunities, and any further data you may need to thrive in the BNP and NTproBNP industry. This BNP and NTproBNP market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bnp and ntprobnp market size has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The expansion witnessed in the historic period can be attributed to several factors, including the aging population demographic, the clinical significance of these tests in diagnosing heart failure, notable advancements in the field of cardiovascular medicine, and an increasing emphasis on preventive healthcare measures.

The bnp and ntprobnp market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. Anticipated growth in the forecast period can be traced back to several key drivers, such as the escalating burden of cardiovascular diseases, the integration of these tests into point-of-care settings, the broadening spectrum of applications across various medical conditions, the implementation of personalized medicine strategies, and the increasing reliance on telemedicine and remote monitoring in healthcare.

The increasing prevalence of cardiovascular diseases is set to drive the growth of the BNP and NTproBNP market moving ahead. These diseases affect the heart and blood vessels, encompassing conditions such as peripheral arterial disease, cerebrovascular disease, and coronary heart disease. BNP and NTproBNP tests play a crucial role in heart health monitoring, aiding in preemptive measures and reducing mortality risks by identifying factors contributing to cardiovascular diseases. For example, according to the UK's Office for National Statistics, deaths attributed to heart attacks rose from 19,440 in 2020 to 20,061 in 2021. This surge in cardiovascular diseases is a catalyst for the BNP and NTproBNP markets' growth.

The expanding geriatric demographic is anticipated to be a driving force for the BNP and NTproBNP market's expansion. This segment, comprising individuals aged 65 or older, finds critical assistance from BNP and NTproBNP tests in diagnosing and managing heart failure. These biomarkers provide valuable insights into cardiac function, aiding in tailored treatment strategies for elderly individuals. The World Health Organization reports that by 2030, one in six individuals globally will be 60 or older, projected to reach 2.1 billion elderly individuals by 2050. Hence, the burgeoning geriatric population propels the growth of the BNP and NTproBNP market.

Innovation in product development emerges as a significant trend driving the BNP and NTproBNP markets. Leading companies in these markets prioritize introducing novel products to maintain their market positions. For instance, in May 2023, Randox Laboratories unveiled a BNP1-32 diagnostic test for heart failure diagnosis. This automated test measures BNP levels with high sensitivity and specificity, integrating with third-party controls and software for effective QC data monitoring. This control ensures accurate and reliable BNP testing.

Prominent companies in the BNP and NTproBNP market are intensifying their focus on rapid screening bioassays to gain a competitive edge. Rapid screening bioassays efficiently assess substance presence or concentration by measuring effects on living cells or organisms, aiding in swift and reliable attribute identification or condition categorization. Mindray Medical International Limited, in October 2023, introduced two new assays-high-sensitivity troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). These assays bolster Mindray's ability to screen, risk-stratify, diagnose rapidly, and monitor therapy for cardiovascular diseases, enhancing their portfolio for efficient disease management. Mindray's collaboration with HyTest further strengthens its immunoassay platforms, integrating advanced research and antibodies for cardiac biomarkers.

In July 2021, Beckman Coulter, a leading US-based clinical diagnostics provider, finalized definitive agreements with Quidel Corporation to secure full rights for manufacturing, distributing, and marketing BNP assays specifically tailored for Beckman Coulter analyzers. As part of this arrangement, Quidel remains responsible for manufacturing and supplying specific components crucial to the assay for Beckman Coulter's use. Meanwhile, Beckman Coulter exclusively handles the production and commercialization of the BNP assay to its customer base, marketing it under the brand name Access BNP. Quidel Corporation, also based in the US, specializes in manufacturing diagnostic healthcare products and operates within the BNP and NTproBNP market segments.

Major companies operating in the bnp and ntprobnp market report are Abbott Laboratories,Gentian Diagnostics ASA,Siemens AG,PerkinElmer Inc.,Biomerieux SA,Quidel Corporation,Bio-Rad Laboratories Inc.,F Hoffman La Roche Ltd.,CTK Biotech Inc.,RayBiotech Life Inc.,BHR Pharmaceuticals Ltd.,Getein Biotech Inc.,VACURE Biotechnology Co. Ltd.,Bio-Techne Co.,Xiamen Biotime Biotechnology Co. Ltd.,Scripps Laboratories Inc.,Danaher Corporation,Beckman Coulter Inc.,Thermo Fisher Scientific Inc.,Randox Laboratories Ltd.,LSI Medience Corporation,Shionogi & Co. Ltd.,Radiometer Medical ApS,Ortho Clinical Diagnostics,Tosoh Corporation,Aidian Oy,Shenzhen Mindray Bio-Medical Electronics Co. Ltd.,Becton Dickinson and Company,Acon Laboratories Inc.,Response Biomedical Corp.,Nanomix Inc.,Cepheid Inc.,Alere Inc.

Asia-Pacific was the largest region in the BNP and NTproBNP market in 2023. North America is expected to be the fastest-growing region in the global BNP and NTproBNP market report during the forecast period. The regions covered in the bnp and ntprobnp market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bnp and ntprobnp market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The BNP and NTproBNP market includes revenues earned by companies by providing diagnostic and heart disease detection services using BNP (B-type natriuretic peptide) or NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) as biomarkers, BNP and NTproBNP assays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. BNP And NTproBNP Market Characteristics

3. BNP And NTproBNP Market Trends And Strategies

4. BNP And NTproBNP Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global BNP And NTproBNP Market Size and Growth

• 5.1. Global BNP And NTproBNP Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global BNP And NTproBNP Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global BNP And NTproBNP Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. BNP And NTproBNP Market Segmentation

• 6.1. Global BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• BNP (Brain Natriuretic Peptide)
• NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide)
• 6.2. Global BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Point of Care Testing
• Laboratory Testing
• 6.3. Global BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome (ACS)
• Other Applications

7. BNP And NTproBNP Market Regional And Country Analysis

• 7.1. Global BNP And NTproBNP Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global BNP And NTproBNP Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific BNP And NTproBNP Market

• 8.1. Asia-Pacific BNP And NTproBNP Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China BNP And NTproBNP Market

• 9.1. China BNP And NTproBNP Market Overview
• 9.2. China BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India BNP And NTproBNP Market

• 10.1. India BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan BNP And NTproBNP Market

• 11.1. Japan BNP And NTproBNP Market Overview
• 11.2. Japan BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia BNP And NTproBNP Market

• 12.1. Australia BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia BNP And NTproBNP Market

• 13.1. Indonesia BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea BNP And NTproBNP Market

• 14.1. South Korea BNP And NTproBNP Market Overview
• 14.2. South Korea BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe BNP And NTproBNP Market

• 15.1. Western Europe BNP And NTproBNP Market Overview
• 15.2. Western Europe BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK BNP And NTproBNP Market

• 16.1. UK BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany BNP And NTproBNP Market

• 17.1. Germany BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France BNP And NTproBNP Market

• 18.1. France BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy BNP And NTproBNP Market

• 19.1. Italy BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain BNP And NTproBNP Market

• 20.1. Spain BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe BNP And NTproBNP Market

• 21.1. Eastern Europe BNP And NTproBNP Market Overview
• 21.2. Eastern Europe BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia BNP And NTproBNP Market

• 22.1. Russia BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America BNP And NTproBNP Market

• 23.1. North America BNP And NTproBNP Market Overview
• 23.2. North America BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA BNP And NTproBNP Market

• 24.1. USA BNP And NTproBNP Market Overview
• 24.2. USA BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada BNP And NTproBNP Market

• 25.1. Canada BNP And NTproBNP Market Overview
• 25.2. Canada BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America BNP And NTproBNP Market

• 26.1. South America BNP And NTproBNP Market Overview
• 26.2. South America BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil BNP And NTproBNP Market

• 27.1. Brazil BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East BNP And NTproBNP Market

• 28.1. Middle East BNP And NTproBNP Market Overview
• 28.2. Middle East BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa BNP And NTproBNP Market

• 29.1. Africa BNP And NTproBNP Market Overview
• 29.2. Africa BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. BNP And NTproBNP Market Competitive Landscape And Company Profiles

• 30.1. BNP And NTproBNP Market Competitive Landscape
• 30.2. BNP And NTproBNP Market Company Profiles
  • 30.2.1. Abbott Laboratories
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Gentian Diagnostics ASA
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Siemens AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. PerkinElmer Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Biomerieux SA
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global BNP And NTproBNP Market Competitive Benchmarking

32. Global BNP And NTproBNP Market Competitive Dashboard

33. Key Mergers And Acquisitions In The BNP And NTproBNP Market

34. BNP And NTproBNP Market Future Outlook and Potential Analysis

• 34.1 BNP And NTproBNP Market In 2028 - Countries Offering Most New Opportunities
• 34.2 BNP And NTproBNP Market In 2028 - Segments Offering Most New Opportunities
• 34.3 BNP And NTproBNP Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer